Liquid stable virus vaccines

Fusion proteins and combination vaccines comprising Protein E and Pilin A

Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses

Combination vaccine

Immunogenic composition for immune system modulation and use thereof, method for treating and preventing diseases, method for inducing cell regeneration and method for restoring immune response

CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses

Compositions comprising chimeric OSPA molecules and methods of use thereof

Method of providing protective immunity against heterologous leptospira strains

Adenovirus serotype 26 and serotype 35 filovirus vaccines

Protein complex system for increased immunogenicity and functionality, and methods making and use

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

Compositions and methods

Soluble needle arrays for delivery of influenza vaccines

Aluminum compounds for use in therapeutics and vaccines

Norovirus vaccine formulations

Consensus antigen constructs and vaccines made therefrom, and methods of using the same to treat malaria

Norovirus vaccine formulations

Adjuvanted influenza vaccines for pediatric use

Parenteral norovirus vaccine formulations

Vaccines with live bacterial isolates for systemic administration

Antigen-Norovirus P-domain monomers and dimers, antigen Norovirus P-particle molecules, and methods for their making and use

PCV/mycoplasma hyopneumoniae/PRRS combination vaccine

PCV/combination vaccine

vaccine

Method for inducing an immune response against avian, swine, spanish, H1N1, H5N9 influenza viruses and formulations thereof

Peptide sequences and compositions

Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)

Recombinant subunit dengue virus vaccine

Composite antigenic sequences and vaccines

BVDV vaccine

Combinations of meningococcal factor H binding proteins

Vaccine for protection against and Porcine circo virus

Personalized site-specific immunomodulation

Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies

Subunit vaccines for herpes viruses and methods of use

Influenza vaccine

V. Cholera hypereexpressing recombinant cholera toxin B subunit showing dual immunogenicity

Compositions and methods for treating influenza

Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens

Pan-lyssavirus vaccines against rabies

Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules

Universal dengue virus sequences and methods of use

Piscine reovirus immunogenic compositions

Universal vaccine against H5N1 lineages

DNA-PROTEIN VACCINATION PROTOCOLS

Targeted heterologous antigen presentation on calicivirus virus-like particles

Immunogenic composition

NOVEL IMMUNOGENS AND METHODS FOR DISCOVERY AND SCREENING THEREOF

RECOMBINANT MULTIMERIC INFLUENZA PROTEINS

HERPES SIMPLEX VIRUS COMBINED SUBUNIT VACCINES AND METHODS OF USE THEREOF

Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

IMMUNOGENIC COMPOSITION

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS

Multiple vaccination including serogroup C meningococcus

Multiple vaccination including serogroup C meningococcus

Process for manufacturing vaccines

VACCINE COMPOSITION

IN SITU CONSTITUTING A VACCINE FOR ADMINISTRATION TO A PREDETERMINED HERD OF ANIMALS

Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses

OUTER MEMBRANE VESICLE (OMV) VACCINE COMPRISING N. MENINGITIDIS SEROGROUP B OUTER MEMBRANE PROTEINS

Live vaccine for avian diseases

Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Malarial Infections

LENTIVIRUS VACCINE BASED ON THE RECOMBINANT VIRAL VACCINE AGAINST YELLOW FEVER

1C31 nanoparticles

Antigen peptide and use thereof

HENDRA VIRUS RECOMBINANT COMPOSITIONS AND USES THEREOF

MATERIALS AND METHODS FOR DETECTING, PREVENTING, AND TREATING RETROVIRAL INFECTION

CONSENSUS SEQUENCE FOR INFLUENZA A VIRUS

Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals

Refrigerator-temperature stable influenza vaccine compositions

Vaccines containing canine parvovirus genetic variants

Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Nipah Infections

Polyvalent conjugate vaccine for cancer

Immunogenic anti-inflammatory compositions

Multivalent pneumococcal polysaccharide-protein conjugate composition

COMBINATION VACCINES AGAINST RESPIRATORY TRACT DISEASES

PROTEIN MATRIX VACCINES OF IMPROVED IMMUNOGENICITY

Multi-epitopic vaccine

Vaccine Having a Peptide Adjuvant for Eliciting a Specific Immune Response to Treat Viral Infection and Other Conditions

Glassy compositions

Glassy compositions

ADJUVANTED NANOPARTICULATE INFLUENZA VACCINE

Peptide sequences and compositions

COMBINATION THERAPY FOR IMMUNOSTIMULATION

Alphavirus replicon particles as immunological adjuvants

Functional influenza virus-like particles (VLPs)

Vaccine composition

POLYMER PARTICLES AND USES THEREOF

Transcutaneous immunization without heterologous adjuvant

POLYANIONIC POLYMER ADJUVANTS FOR HAEMOPHILUS INFLUENZAE B SACCHARIDE VACCINES

HLA-A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND COMPOSITIONS

PAPILLOMAVIRUS VACCINE COMPOSITIONS

ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISM

Vaccine

Norovirus vaccine formulations

COMPOSITIONS AND METHODS FOR VACCINATING CATTLE

Adjuvanting meningococcal factor H binding protein

Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications

Induction of an immune response against dengue virus using the prime-boost approach

Vaccine

COMBINATION NEISSERIAL COMPOSITIONS

Influenza virus vaccine composition and methods of use

Replication-Defective Flavivirus Vaccine Vectors Against Respiratory Syncytial Virus

Chimeric viruses presenting non-native surface proteins and uses thereof

Method to enhance an immune response of nucleic acid vaccination

Chimeric factor H binding proteins (fHbp) and methods of use

Mosaic clade M human immunodeficiency virus type 1 (HIV-1) gag immunogens

Lipidated polyepitope vaccines

Programming of cells for tolerogenic therapies

Combined measles-malaria vaccine

Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region

Multivalent nanoemulsion vaccines

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactant

Vaccine for cervical cancer

Norovirus capsid and rotavirus VP6 protein for use as combined vaccine

NOROVIRUS VACCINE FORMULATIONS

INFLUENZA VACCINES WITH INCREASED AMOUNTS OF H3 ANTIGEN

NOVEL COMPOSITIONS

Influenza vaccines with reduced amounts of squalene

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

METHOD FOR KEEPING A FOOT-AND-MOUTH DISEASE VACCINE AVAILABLE FOR EMERGENCY VACCINATION

ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

Tetravalent influenza vaccine and use thereof

COMBINATIONS OF MENINGOCOCCAL FACTOR H BINDING PROTEIN AND PNEUMOCOCCAL SACCHARIDE CONJUGATES

proteins and nucleic acids

Vaccines for human papilloma virus and methods for using the same

STAPHYLOCOCCUS AUREUS PROTEINS AND NUCLEIC ACIDS

INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

RECOMBINANT PARAINFLUENZA VIRUS VACCINE COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM RESPIRATORY SYNCYTIAL VIRUS

Influenza virus vaccine composition and methods of use

Methods for one-dose intradermal delivery for non-live trivalent influenza vaccine

KITS FOR ONE-DOSE INTRADERMAL DELIVERY FOR NON-LIVE TRIVALENT INFLUENZA VACCINE

ADJUVANTED INFLUENZA VACCINES FOR PEDIATRIC USE

Dose selection of adjuvanted synthetic nanocarriers

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

Chimeric OspA genes, proteins, and methods of use thereof

proteins and nucleic acids

Avirulent, immunogenic flavivirus chimeras

INFLUENZA VIRUS COMPOSITIONS AND METHODS FOR UNIVERSAL VACCINES

Meningococcal And Pneumococcal Conjugate Vaccine And Method Of Using Same

CONJUGATES UTILIZING PLATFORM TECHNOLOGY FOR STIMULATING IMMUNE RESPONSE

Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction

Ex-vivo passive protection bacteremia assay

RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE

MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH NON-HIB VACCINES

Mixing lyophilised meningococcal vaccines with D-T-Pa vaccines

Multiple vaccination including serogroup C Meningococcus

APPLICATION OF MRNA FOR USE AS A THERAPEUTIC AGAINST TUMOUR DISEASES

Infectious bronchitis vaccines derived from IB-QX-like vaccine strains

Vaccines against multiple subtypes of influenza virus

Nucleic acids encoding mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens

Peptide particle formulation

IgE CH3 peptide vaccine

SYNTHETIC NANOCARRIER COMBINATION VACCINES

MULTIVALENT SYNTHETIC NANOCARRIER VACCINES

NANOCARRIER COMPOSITIONS WITH UNCOUPLED ADJUVANT

Chimeric OspA genes, proteins, and methods of use thereof

MULTIVALENT ADJUVANTED INFLUENZA VIRUS COMPOSITIONS

METHOD AND APPARATUS FOR THE DELIVERY OF PLYNUCLEOTIDE VACCINES TO MAMMALIA SKIN

Live attenuated chimeric porcine circovirus vaccine

Capsular gram-positive bacteria bioconjugate vaccines

Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma

VACCINE COMPOSITIONS FOR THE TREATMENT OF DENGUE FEVER AND USES THEREOF

SINGLE-TIME VACCINES

Vaccine composition for use against influenza

Optimized influenza vaccines

Soft gel delivery system for treating poultry

Vaccine

COMPOSITIONS AND METHODS FOR TREATING EBOLA VIRUS INFECTION

Vaccines

Vaccine Composition

Vaccine compositions comprising a saponin adjuvant

Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof

Combination vaccine with acellular pertussis

MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION

Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen

COMBINED INFLUENZA VACCINES FOR SEASONAL AND PANDEMIC PROTECTION

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity

Tissue targeted antigenic activation of the immune response to treat cancers

COMBINATION VACCINE WITH WHOLE CELL PERTUSSIS

Compositions Comprising Salmonella Porins and Uses Thereof as Adjuvants and Vaccines

VACCINE AGAINST HPV

Immunization compositions and methods

ADJUVANTED INFLUENZA VACCINES INCLUDING CYTOKINE-INDUCING AGENTS

INFLUENZA DNA VACCINATION AND METHODS OF USE THEREOF

POLYVALENT, PRIMARY HIV-1 GLYCOPROTEIN DNA VACCINES AND VACCINATION METHODS

Astrovirus

SYNTHETIC VIRUS-LIKE PARTICLES CONJUGATED TO HUMAN PAPILLOMAVIRUS CAPSID PEPTIDES FOR USE AS VACCINES

Method and apparatus for the delivery of polynucleotide vaccines to mammalian skin

Rabies virus-based recombinant immunocontraceptive compositions and methods of use

STABLE POWDER FORMULATIONS OF ALUM-ADSORBED VACCINES

West Nile Virus vaccine

Avian reoviridae and vaccines thereof

INFLUENZA VACCINES

Fusion proteins and use thereof for preparing hepatitis C vaccines

Chimeric west nile/dengue viruses

MULTIVALENT VACCINE AGAINST PORCINE TESCHOVIRUS AND OTHER DISEASE CAUSING ORGANISMS IN SWINE

Replication-defective flavivirus vaccines and vaccine vectors

Combined measles-human papilloma vaccine

NOVEL USE

Infectious bursal disease virus antigenic isolates and vaccines

Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device

Multiclade HIV Vaccines

MVA expressing modified HIV envelope, gag, and pol genes

COMBINATION NEISSERIAL COMPOSITIONS

COMPOSITIONS AND METHODS FOR TREATING INFLUENZA

Virus-like particles as vaccines for paramyxovirus

Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

Inactivated Live-Attenuated Bluetongue Virus Vaccine

VACCINE COMPOSITIONS AND USES THEREOF

NOVEL VACCINE FOR DOG

Alphavirus replicon particles matched to protein antigens as immunological adjuvants

COMPOSITION COMPRISING ISCOM PARTICLES AND LIVE MICRO-ORGANISMS

Arabinogalactan for enhancing the adaptive immune response

Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use

Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

Vaccine Antigens from Piscirickettsia Salmonis

RECOMBINANT MODIFIED VACCINIA VIRUS MEASLES VACCINE

Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus

ENHANCEMENT OF IMMUNOGENICITY OF ANTIGENS

VACCINES INCLUDING ANTIGEN FROM FOUR STRAINS OF INFLUENZA VIRUS

Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis

VACCINE FOR PROTECTION AGAINST LAWSONIA INTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCO VIRUS

METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES

Influenza Vaccines Containing Hemagglutinin and Matrix Proteins

PROCESS FOR TREATMENT OF RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

Alphavirus Vectors for Respiratory Pathogen Vaccines

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS, NON-VIRAL BASED CANCERS, ALZHEIMERS'S DISEASE, MUSCULAR DYSTROPHY, ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER, COMPLEX REGIONAL PAIN SYNDROME, DIABETES, NEUROPATHIC PAIN, SPIDER ARTHRITIS, WEST NILE VIRUS, FIBROMYALGIA, SHINGLES, GOUT, MIGRAINE HEADACHES, SENILE DEMENTIA, POST POLIO SYNDROME, CENTRAL VIRUS DEAFNESS, ASTHMA, CHRONIC PAIN OF UNKNOWN ORIGIN AND HEPATITIS C

Vaccine Antigens

Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use

Vaccine formulation potentiated by the combination of DNA and an antigen

Multivalent pneumococcal polysaccharide-protein conjugate composition

COMPOSITION FOR TREATING PROSTATE CANCER (PCa)

Compositions and methods for administration of vaccines against dengue virus

Development of a preventive vaccine for filovirus infection in primates

ADJUVANT

Vectors for multiple gene expression

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

Development of a preventive vaccine for filovirus infection in primates

Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus

Development of a preventive vaccine for filovirus infection in primates

Meningococcal oligosaccharide linked polysaccharides and diptheria protein conjugate vaccine for all ages

Multitype HPV peptide compositions and methods for treatment or prevention of human papillomavirus infection

COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)

Method of eliciting an immune response against pandemic influenza virus

Vaccine

Alpha thymosin peptides as vaccine enhancers

DNA vaccine for treating or preventing cervical cancer comprising a gene encoding HPV protein

Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins

Compositions and Methods

Nipah virus vaccines

Truncated L1 protein of human papillomavirus type 18

Polyvalent chimeric rubella virus-based vaccines

Method of Immunization Against the 4 Dengue Serotypes

Meningococcal and pneumococcal conjugate vaccine and method of using same

Nucleic acids encoding antibodies or portions thereof comprising a heterologous T cell epitope and their use in modulating T cell responses

Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals

Truncated L1 protein of Human Papillomavirus type 16

Avirulent, immunogenic flavivirus chimeras

Truncated L1 protein of human papillomavirus type 6

Composition and method for controlling intestinal pathogenic organisms

Method of Immunization Against the 4 Serotypes of Dengue Fever

Vaccine comprising capsular polysaccharide conjugates

Immunogenic Compositions and Methods for Treating and Preventing Animal Infections

Polyanionic polymer adjuvants for B saccharide vaccines

COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE

Method of Immunization Against the 4 Dengue Serotypes

NOVEL VACCINE COMPOSITION

PLANT-PRODUCED COMPOSITIONS FOR TREATING PAPILLOMAVIRUS INFECTION AND RELATED METHODS

PROTECTION OF AN ANIMAL AGAINST PESTIVIRUS INFECTION

Process for manufacturing vaccines

HLA-A2 tumor associated antigen peptides and compositions

Vaccine comprising capsular polysaccharide conjugates

FORMULATION OF MENINGITIS VACCINES

INFLUENZA VIRUS VACCINE COMPOSITION AND METHODS OF USE

PAPILLOMAVIRUS VACCINE COMPOSITIONS

Oil-in-water emulsion influenza vaccine

Vaccine Comprising an Oil in Water Emulsion Adjuvant

VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES

Method of treating pregnant cows and/or heifers

Microfluidized oil-in-water emulsions and vaccine compositions

Influenza vaccines

ADMINISTRATION ROUTES FOR PRIMING/BOOSTING WITH INFLUENZA VACCINES

MANUFACTURE OF BOOSTER VACCINES HAVING REDUCED ANTIGEN DOSES

Tetravalent Dengue Vaccines

THERAPY OF CANCER BASED ON TARGETING ADAPTIVE, INNATE AND/OR REGULATORY COMPONENT OF THE IMMUNE RESPONSE

METHODS OF REDUCING PORCINE CIRCOVIRUS-ASSOCIATED DISEASE OUTBREAKS

INTRADERMAL INFLUENZA VACCINE

Functional influenza virus like particles (VLPs)

EFFECTIVE METHOD OF TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS

hyperexpressing recombinant cholera toxin B subunit showing dual immunogenicity

RECOMBINANT MULTIVALENT VACCINE

Vaccine

METHODS AND COMPOSITIONS FOR PREPARING A UNIVERSAL INFLUENZA VACCINE

Hypo- and Hyper- Acetylated Meningococcal Capsular Saccharides